Exponent, Inc. is a science and engineering consulting firm that provides solutions to complex problems through interdisciplinary teams of scientists, physicians, engineers, and business consultants. The company operates in two reportable segments: Engineering and Other Scientific, and Environmental and Health. Its 17 practices include Biomechanics, Biomedical Engineering & Sciences, Civil & Structural Engineering, Construction Consulting, Data Sciences, Electrical Engineering & Computer Science, Human Factors, Materials Science & Electrochemistry, Mechanical Engineering, Metallurgical & Corrosion Engineering, Polymers & Chemistry, Thermal Sciences, Vehicle Engineering, Chemical Regulation & Food Safety, Ecological & Biological Sciences, Environmental & Earth Sciences, and Health Sciences. Exponent serves clients in the chemical, construction, consumer products, energy, food, beverage, government, life sciences, insurance, manufacturing, technology, and transportation sectors. Many engagements are initiated by large corporations, lawyers, or insurance companies for litigation support, failure prevention, and technology evaluation. The firm was founded in 1967 as Failure Analysis Associates, a partnership of Stanford University professors and engineers, and changed its name to Exponent, Inc. in 1998. It operates a Test & Engineering Center in Phoenix, Arizona, and has offices in the United States, Europe, and Asia.

Summarised from the company's own disclosures, fiscal year ended Feb 2026

Industry Consulting Services Homepage exponent.com
Sector Industrials IR page investors.exponent.com/investors/overview/default.aspx
Tags
failure analysis, biomechanics, biomedical engineering, civil engineering, construction consulting, data sciences, electrical engineering, human factors, materials science, mechanical engineering, metallurgy, polymers chemistry, Failure Analysis Associates, The Failure Group, Environmental Health Strategies, PTI Environmental Services, Novigen Sciences, Test & Engineering Center
Press page exponent.com/announcements

Metrics

Valuation  
Market cap $ 4.11B
Market cap (USD) $ 4.11B
P/E 37.42
PEG 31.60
P/BV 13.35
P/S 6.24
P/OCF 27.64
P/FCF 29.23
Dividend yield 1.4%
Turnover / mcap —
Returns  
ROE 26.1%
ROI 43.4%
ROIC 35.3%
Profit margin 18.2%
Growth  
Revenue growing Yes
Profits growing No
Revenue up 3y Yes
Revenue up 5y Yes
Earnings growth 3y (net profit CAGR) 1.2%
Quality  
Profitable Yes
Margin expanding No
Buying back stock Yes
Diluting (TTM) No
Debt/Equity —
Podcast bulls (TTM) Sign up
Podcast bears (TTM) Sign up
Podcast sentiment (TTM) Sign up
Podcast sentiment % (TTM) Sign up
News sentiment (TTM) 45
Quality score 22.2%
Insiders  
Buys, 1w Sign up
Buys, 1m Sign up
Buys, 1y Sign up
Sells, 1w Sign up
Sells, 1m Sign up
Sells, 1y Sign up

Sign up to see this company's insider trades

Figure FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 FY 2018 FY 2017 FY 2016 FY 2015 FY 2014 FY 2013 FY 2012 FY 2011 FY 2010 FY 2009 FY 2008 FY 2007 FY 2006 FY 2005 FY 2004 FY 2003 FY 2002 FY 2001 FY 2000
Revenue 582.014M 558.514M 536.766M 513.293M 466.269M 399.9M 417.199M 379.523M 347.799M 315.076M 312.832M 304.704M 296.168M 292.653M 272.446M 248.753M 227.882M 227.882M 205.148M 168.496M 155.196M 151.509M 139.676M 139.676M 104.497M 101.598M
Net profit 106.009M 109.002M 100.339M 102.33M 101.202M 82.552M 82.46M 72.254M 41.305M 47.48M 43.599M 40.701M 38.64M 37.225M 32.695M 27.521M 22.127M 22.127M 20.341M 14.194M 14.186M 12.04M 10.166M 10.166M 6.122M 7.782M
Free cash flow 122.34M 137.598M 110.996M 81.764M 117.742M 98.325M 85.021M 74.89M 63.113M 52.553M 55.11M 43.305M 55.566M 43.563M 42.761M 33.577M 24.799M 24.799M 23.273M 16.377M 10.8M 13.422M 19.347M 19.347M 2.576M 12.36M

Figure FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 FY 2018 FY 2017 FY 2016 FY 2015 FY 2014 FY 2013 FY 2012 FY 2011 FY 2010 FY 2009 FY 2008 FY 2007 FY 2006 FY 2005 FY 2004 FY 2003 FY 2002 FY 2001 FY 2000
Share price 69.46 89.1 88.04 99.09 116.73 90.03 69.01 50.71 71.1 60.3 49.95 82.5 77.29 55.82 47.5 37.5 27.84 28.78 25.97 17.73 26.68 — — — — —
Price performance 12m -0.22 0.01 -0.11 -0.15 0.3 0.3 0.36 -0.29 0.18 0.21 -0.39 0.07 0.38 0.18 0.27 0.35 -0.03 0.11 0.46 -0.34 — — — — — —

Filed figures

Figure Dec 2016 Dec 2017 Dec 2018 Dec 2019 Dec 2020 Dec 2021 Dec 2022 Dec 2023 Dec 2024 Dec 2025
Balance sheet detail
Trade receivables (USD) 87.4M 110M 106M 120M 112M 140M 170M 167M 161M 182M
↳ YoY growth -1.3% +26.0% -3.9% +13.5% -7.1% +25.4% +21.6% -1.6% -3.6% +12.5%
↳ 5y CAGR +3.7% +5.2% +6.6% +6.8% +4.7% +9.9% +9.1% +9.6% +6.1% +10.2%
Lease liabilities (USD) — — 0.00 24.1M 20.3M 15M 18.6M 28.3M 81.5M 82.8M
Cash and deposits (USD) 115M 125M 127M 176M 198M 298M 161M 187M 259M 222M
Right-of-use assets (USD) — — 0.00 23M 19.3M 14.4M 18M 24.6M 75.2M 73.4M
Cash flow detail
Operating cash flow (USD) 66.9M 67.8M 91.2M 108M 103M 125M 93.8M 127M 145M 132M
Purchases of property, plant and equipment (USD) -14.4M -4.73M -16.3M -23M -4.99M -6.83M -12M -16.4M -6.94M -9.39M
Change in receivables (cash effect) (USD) -1.28M -25.2M 2.44M -16.5M 6.72M -30.3M -33.3M -471,000 1.5M -23.1M
Change in payables (cash effect) (USD) -370,000 5.98M -4.62M 6.72M -2.65M 8.44M 2.22M -5.06M 436,000 7.68M
Dividends paid (cash effect) (USD) -18.6M -21.6M -27M -33.1M -39.4M -41.7M -49.1M -52.7M -56.8M -60.4M
Share buybacks (cash effect) (USD) -24.5M -11.9M -27.9M -22M -40M -7M -156M -24.2M -5.71M -97.1M
Income taxes paid (cash effect) (USD) -22.3M -25.8M -28.6M -21.4M -20.1M -27.9M -40.1M -38.9M -39.7M -48M
Share-based compensation (USD) 13.3M 16.2M 17M 17.5M 17.3M 19.3M 20.4M 20.4M 23.2M 23.8M
Operating cash flow before change in receivables (USD) 68.2M 93M 88.8M 125M 96.6M 155M 127M 128M 143M 155M
Free cash flow (OCF - PPE - intangibles) (USD) 52.6M 63.1M 74.9M 85M 98.3M 118M 81.8M 111M 138M 122M
Income detail
Total comprehensive income (USD) 46.2M 42.4M 71.4M 83.6M 82.4M 101M 101M 101M 108M 108M
Comprehensive income to owners (USD) 46.2M 42.4M 71.4M 83.6M 82.4M 101M 101M 101M 108M 108M
Provision for credit losses (USD) 2.45M 2.51M 1.85M 2.22M 1.85M 1.96M 3.08M 3.23M 4.45M 2.99M
Credit cost ratio (credit losses / average receivables) (%) 2.8% 2.5% 1.7% 2.0% 1.6% 1.6% 2.0% 1.9% 2.7% 1.7%
Reported Feb 24, 2017 Feb 23, 2018 May 3, 2019 Feb 28, 2020 Feb 26, 2021 Feb 25, 2022 Feb 24, 2023 Feb 23, 2024 Feb 28, 2025 Feb 27, 2026

Sign up to see institutional holdings

Sign Up

Podcast Mentions

Sign up to see podcast mentions and sentiment

Sign Up

10/29/2026

Download(opens in new window)

MENLO PARK, Calif., Oct. 29, 2026 (GLOBE NEWSWIRE) -- Exponent, Inc. (Nasdaq: EXPO) today reported financial results for the third quarter of fiscal year 2026 ended October 2, 2026.

“Exponent delivered another strong quarter, with double-digit growth in revenues and earnings, reflecting continued demand for our specialized, integrated engineering and scientific expertise,” stated Dr. Catherine Corrigan, Chief Executive Officer. “User research studies continued to be a strong contributor to our growth, as clients move quickly to understand how people interact with technology across a widening range of devices and applications. Reactive work also grew, on top of a strong prior-year quarter, with increased dispute-related and failure analysis demand in the chemical, consumer products and transportation industries.

“These results reflect the durable, long-term trends shaping our business, including rapid technological innovation, increasing complexity, investment in critical infrastructure, and rising societal expectations for safety and reliability. As artificial intelligence and other digital technologies become increasingly embedded into physical systems, the digital and physical worlds are converging. Exponent is differentiated at that convergence, where data and computation meet real-world evidence, and where technology must ultimately work for the user. Our multidisciplinary scientists and engineers bring together deep domain expertise, scientific rigor, and an understanding of complex physical systems to help clients innovate with confidence, solve their most challenging problems, and manage high-consequence risk,” Dr. Corrigan continued.

Third Quarter Financial Results

Total revenues and revenues before reimbursements for the third quarter of 2026 increased 18% to $173.7 million and 12% to $153.1 million, respectively, as compared to $147.1 million and $137.1 million in the third quarter of 2025.

Net income increased to $30.9 million, or $0.64 per diluted share, in the third quarter of 2026, as compared to $28.0 million, or $0.55 per diluted share, in the same period of 2025. The tax benefit associated with share-based awards was immaterial in both the third quarter of 2026 and 2025. Inclusive of the tax benefit, Exponent’s consolidated tax rate was 28.0% in the third quarter of 2026, as compared to 27.4% for the same period in 2025.

EBITDA1 increased to $45.0 million, or 29.4% of revenues before reimbursements, in the third quarter of 2026, as compared to $38.8 million, or 28.3% of revenues before reimbursements in the third quarter of 2025.

Year to Date Financial Results

Total revenues and revenues before reimbursements for the first three quarters of 2026 increased 18% to $511.6 million and 11% to $453.7 million, respectively, as compared to $434.6 million and $407.4 million in the same period of 2025.

Net income increased to $89.9 million, or $1.83 per diluted share, through the first three quarters of 2026, as compared to $81.2 million, or $1.58 per diluted share, in the same period of 2025. During the first three quarters of 2026, we realized a negative tax impact associated with share-based awards of $0.8 million, as compared to $0.4 million during the same period one year ago. Inclusive of the tax impact associated with share-based awards, Exponent’s consolidated tax rate was 28.7% through the first three quarters of 2026, as compared to 28.2% for the same period last year.

EBITDA1 increased to $130.8 million, or 28.8% of revenues before reimbursements, through the first three quarters of 2026, as compared to $113.4 million, or 27.8% of revenues before reimbursements, in the same period of 2025.

Through the first three quarters of 2026, Exponent paid $46.1 million in dividends, repurchased $146.1 million of common stock, and closed the period with $114.7 million in cash and cash equivalents.  

In a separate press release today, Exponent announced its quarterly cash dividend of $0.31 to be paid on December 18, 2026, and reiterated its intent to continue to pay quarterly dividends.

Business Overview

Exponent’s engineering and other scientific segment represented 85% of the Company’s revenues before reimbursements in the third quarter and through the first three quarters of 2026. Revenues before reimbursements in this segment increased 13% in the third quarter and through the first three quarters of 2026, as compared to the prior year period. Growth during the quarter was driven by strong user research activity spanning a broad set of challenges, including health applications, dynamic and unstructured real-world environments, and sensory perception. Dispute-related services involving chemical facilities, consumer products and advanced transportation technologies also drove growth in the quarter, as clients rely on Exponent in critical, high-stakes situations.

Exponent’s environmental and health segment represented 15% of the Company’s revenues before reimbursements in the third quarter and through the first three quarters of 2026. Revenues before reimbursements in this segment increased 3% in the third quarter and 4% through the first three quarters of 2026, as compared to the prior year period. Growth in this segment was driven by increased projects assessing the effects of chemicals on human health and the environment.

Business Outlook

“Our ability to scale our operating model in response to market demand resulted in 77% utilization and expanded profitability during the third quarter of 2026. We are encouraged by the market opportunities across the industries we serve and continue to strategically build upon our diversified portfolio of talent and capabilities,” commented Eric Anderson, Chief Financial Officer. “As we close out 2026, we are raising our full-year revenue and margin guidance, reflecting the strength of our year-to-date performance and our outlook for the remainder of the year. Looking ahead, we remain confident in Exponent’s long-term growth trajectory and our ability to capitalize on the strong demand for our differentiated expertise.”

For the fourth quarter of fiscal 2026 as compared to the same period one year prior, Exponent anticipates:

  • Revenues before reimbursements to grow 8% to 10%; and,
  • EBITDA1 to be 26.3% to 26.8% of revenues before reimbursements.

For the full fiscal year 2026 as compared to fiscal year 2025, Exponent anticipates:

  • Revenues before reimbursements to grow 10% to 11%; and,
  • EBITDA1 to be 28.0% to 28.3% of revenues before reimbursements.

“Rapid innovation continues to reshape industries as companies race to make physical products more intelligent, while expectations for safety, reliability, and performance continue to rise. Exponent is built for this moment. We help clients navigate these increasingly complex challenges, whether validating AI-enabled systems, strengthening critical infrastructure, or understanding how people interact with the technologies around them. Across these areas, our integrated platform brings the scientific and engineering expertise needed to deliver explainability, clarity, and trust. This distinctive ecosystem, together with strong long-term growth drivers, positions Exponent to deliver sustainable value for our clients and shareholders,” concluded Dr. Corrigan.

Today's Conference Call Information

Exponent will discuss its financial results in more detail on a conference call today, Thursday, October 29, 2026, starting at 4:30 p.m. Eastern Time / 1:30 p.m. Pacific Time. The audio of the conference call is available by dialing (844) 481-2781 or (412) 317-0672. A live webcast of the call will be available on the Investor Relations section of the Company's website at www.exponent.com/investors . For those unable to listen to the live webcast, a replay of the call will also be available on the Exponent website, or by dialing (855) 669-9658 or (412) 317-0088 and entering passcode 5957331#.

Use of non-GAAP Financial Measures 1

EBITDA is a non-GAAP financial measure defined by the Company as net income before income taxes, interest income, depreciation, and amortization. EBITDAS is a non-GAAP financial measure defined by the Company as EBITDA before stock-based compensation. The Company regards EBITDA and EBITDAS as useful measures of operating performance and cash flow to complement operating income, net income, and other GAAP financial performance measures. Additionally, management believes that EBITDA and EBITDAS provide meaningful comparisons of past, present, and future operating results. Generally, a non-GAAP financial measure is a numerical measure of a company's performance, financial position, or cash flow that either excludes or includes amounts that are not normally excluded or included in the most directly comparable measure calculated and presented in accordance with GAAP. These measures, however, should be considered in addition to, and not as a substitute or superior to, operating income, cash flows, or other measures of financial performance prepared in accordance with GAAP.

Exponent has provided its outlook regarding EBITDA as a percentage of revenues before reimbursements. The Company has not reconciled this non-GAAP financial measure to the corresponding GAAP financial measure because guidance for the various reconciling items is not provided and the Company is unable to estimate with reasonable certainty the effect of these items without unreasonable effort. For example, the Company is unable to estimate with reasonable certainty the impact of equity awards on Exponent’s taxes without unreasonable effort. These items are uncertain, depend on various factors, and may have a material effect on Exponent’s results computed in accordance with GAAP. A reconciliation between the historical GAAP and non-GAAP financial measures presented in this release is provided in the financial tables at the end of this release.

About Exponent

Exponent brings together 90+ technical disciplines and 950+ consultants to help our clients navigate the increasing complexity of more than a dozen industries, connecting decades of pioneering work in failure analysis to develop solutions for a safer, healthier, more sustainable world.

Exponent’s consultants deliver the highest value by leveraging multidisciplinary expertise and resources from across Exponent’s offices in North America, Asia, and Europe. Exponent’s consultants, laboratories, databases, and computing resources work seamlessly together around the globe, enabling us to produce the breakthrough insights needed to help multinational companies, startups, law firms, insurance companies, governments, and society respond to incidents and push their products and processes forward.

Exponent may be reached at (888) 656-EXPO, [email protected], or www.exponent.com.

Forward Looking Statements

This news release contains, and incorporates by reference, certain “forward-looking” statements (as such term is defined in the Private Securities Litigation Reform Act of 1995, and the rules promulgated pursuant to the Securities Act of 1933, as amended, and the Securities Exchange Act of 1934, as amended) that are based on the beliefs of the Company’s management, as well as assumptions made by and information currently available to the Company’s management. When used in this document and in the documents incorporated herein by reference, the words “intend,” “anticipate,” “believe,” “estimate,” “expect” and similar expressions, as they relate to the Company or its management, identify such forward-looking statements. Such statements reflect the current views of the Company or its management with respect to future events and are subject to certain risks, uncertainties and assumptions. Should one or more of these risks or uncertainties materialize, or should underlying assumptions prove incorrect, the Company’s actual results, performance, or achievements could differ materially from those expressed in, or implied by, any such forward-looking statements. Factors that could cause or contribute to such material differences include the possibility that the demand for our services may decline as a result of changes in generally applicable and industry-specific economic conditions, the timing of engagements for our services, the effects of competitive services and pricing, the absence of backlog related to our business, our ability to attract and retain key employees, the effect of tort reform and government regulation on our business, and liabilities resulting from claims made against us. Additional risks and uncertainties are discussed in our Annual Report on Form 10-K under the heading “Risk Factors” and elsewhere in the report. The inclusion of such forward-looking information should not be regarded as a representation by the Company or any other person that the future events, plans, or expectations contemplated by the Company will be achieved. The Company undertakes no obligation to release publicly any updates or revisions to any such forward-looking statements.

Source: Exponent, Inc.

EXPONENT, INC.
CONDENSED CONSOLIDATED STATEMENTS OF INCOME
For the Quarters Ended October 2, 2026 and October 3, 2025
(unaudited)
(in thousands, except per share data)
Quarter Ended Nine Months Ended
October 2, October 3, October 2, October 3,
2026 2025 2026 2025
Revenues
Revenues before reimbursements $ 153,063 $ 137,073 $ 453,740 $ 407,378
Reimbursements 20,670 10,047 57,908 27,211
Revenues 173,733 147,120 511,648 434,589
Operating expenses
Compensation and related expenses 90,038 87,726 282,018 261,103
Other operating expenses 13,814 12,655 39,504 36,822
Reimbursable expenses 20,670 10,047 57,908 27,211
General and administrative expenses 7,334 7,654 20,940 18,806
131,856 118,082 400,370 343,942
Operating income 41,877 29,038 111,278 90,647
Other income (expense), net
Interest income, net 668 2,312 3,102 7,370
Miscellaneous income (expense), net 448 7,267 11,718 15,175
1,116 9,579 14,820 22,545
Income before income taxes 42,993 38,617 126,098 113,192
Income taxes 12,050 10,573 36,191 31,945
Net income $ 30,943 $ 28,044 $ 89,907 $ 81,247
Net income per share:
Basic $ 0.64 $ 0.55 $ 1.84 $ 1.59
Diluted $ 0.64 $ 0.55 $ 1.83 $ 1.58
Shares used in per share computations:
Basic 48,131 50,872 48,891 51,113
Diluted 48,422 51,179 49,195 51,454
EXPONENT, INC.
CONDENSED CONSOLIDATED BALANCE SHEETS
October 2, 2026 and January 2, 2026
(unaudited)
(in thousands)
October 2, January 2,
2026 2026
Assets
Current assets:
Cash and cash equivalents $ 114,689 $ 221,930
Accounts receivable, net 209,604 181,507
Prepaid expenses and other assets 28,976 24,143
Total current assets 353,269 427,580
Property, equipment and leasehold improvements, net 69,900 71,981
Operating lease right-of-use asset 68,208 73,376
Goodwill 8,607 8,607
Other assets 193,092 195,975
$ 693,076 $ 777,519
Liabilities and Stockholders' Equity
Current liabilities:
Accounts payable and accrued liabilities $ 34,733 $ 30,942
Accrued payroll and employee benefits 121,993 121,302
Deferred revenues 18,503 18,868
Operating lease liability 6,533 6,890
Total current liabilities 181,762 178,002
Other liabilities 128,822 133,232
Operating lease liability 74,606 75,944
Total liabilities 385,190 387,178
Stockholders' equity:
Common stock 66 66
Additional paid-in capital 392,784 369,747
Accumulated other comprehensive loss (2,496 ) (2,290 )
Retained earnings 712,318 668,423
Treasury stock, at cost (794,786 ) (645,605 )
Total stockholders' equity 307,886 390,341
$ 693,076 $ 777,519
EXPONENT, INC.
EBITDA and EBITDAS (1)
For the Quarters Ended October 2, 2026 and October 3, 2025
(unaudited)
(in thousands)
Quarter Ended Nine Months Ended
October 2, October 3, October 2, October 3,
2026 2025 2026 2025
Net Income $ 30,943 $ 28,044 $ 89,907 $ 81,247
Add back (subtract):
Income taxes 12,050 10,573 36,191 31,945
Interest income, net (668 ) (2,312 ) (3,102 ) (7,370 )
Depreciation and amortization 2,651 2,532 7,844 7,544
EBITDA (1) 44,976 38,837 130,840 113,366
Stock-based compensation 6,694 5,341 22,432 18,767
EBITDAS (1) $ 51,670 $ 44,178 $ 153,272 $ 132,133
(1) EBITDA is a non-GAAP financial measure defined by the Company as net income before income taxes, interest income, depreciation and amortization. EBITDAS is a non-GAAP financial measure defined by the Company as EBITDA before stock-based compensation. The Company regards EBITDA and EBITDAS as useful measures of operating performance and cash flow to complement operating income, net income and other GAAP financial performance measures. Additionally, management believes that EBITDA and EBITDAS provide meaningful comparisons of past, present and future operating results. Generally, a non-GAAP financial measure is a numerical measure of a company's performance, financial position or cash flow that either excludes or includes amounts that are not normally excluded or included in the most directly comparable measure calculated and presented in accordance with GAAP. These measures, however, should be considered in addition to, and not as a substitute or superior to, operating income, cash flows, or other measures of financial performance prepared in accordance with GAAP.

Primary Logo

Source: Exponent, Inc.

View All News and Events

Need more information?

Investor Relations Exponent, Inc. 149 Commonwealth Drive, Menlo Park, CA 94025 (650) 326-9400

[email protected]

Subscribe to Investor News Alerts

Sign up to be notified when new press releases are posted.

Email Address *

Email

Email Address is required

First Name *

First Name

First Name is required

Last Name *

Last Name

Last Name is required

Exponent is committed to protecting and respecting your privacy. We collect and use your personal information to administer your account and to provide the products and services you requested from us. From time to time, we may also contact you about our products and services, as well as other content that may be of interest to you with your permission. You can unsubscribe from these communications at any time. If you consent to us contacting you for this purpose,please tick below to say how you would like us to contact you:

I agree to receive other communications from Exponent.

Tom Watt Joins Exponent as New Principal Bull 1 Bear 0 Management

Share

October 29, 2026

Exponent welcomes Tom Watt to our Computer, Data & Security Sciences practice, strengthening our capabilities in systems engineering and complex technology development 

Exponent is pleased to welcome Tom Watt as a principal in our Computer, Data & Security Sciences practice in London. Over a career spanning three decades, he has led the development of novel technologies, integrated products, and large-scale systems across a wide range of industries. 

Mr. Watt specializes in systems engineering, innovation management, research and development leadership, and the execution of complex technology programs. Throughout his career, he has helped organizations rapidly advance new concepts into qualified systems, develop technical and corporate strategies, establish new organizational capabilities, and navigate safety-critical and regulated environments.

Before joining Exponent, Mr. Watt served on the leadership team at a major technology incubator focused on med tech, where he owned large consulting assignments and helped expand the organization's ability to deliver complex systems across the development lifecycle. Across his career, he has led research and development in defense, transport, logistics, fast-moving consumer goods (FMCG), healthcare and medical devices, with a focus on novel and disruptive technologies.

Earlier in his career, Mr. Watt led systems engineering, safety, quality, and regulatory functions for organizations developing complex technologies in highly regulated environments. He also served as Design Authority for a £100 million government program recognized for its innovative approach and rapid delivery. His broader experience includes developing data and digital strategies, advancing security-critical systems, accelerating technology development efforts, and directing multidisciplinary teams across large-scale research and innovation programs.

Mr. Watt earned a first-class B.Sc. with honors in laser physics and optoelectronic engineering from the University of St Andrews. He is a member of the International Council on Systems Engineering (INCOSE), the Institution of Engineering and Technology (IET), Institute of Electrical and Electronics Engineers (IEEE), and the Institute of Physics, and he is an Industrial Fellow at the University of Cambridge.

Tom Watt

"I love working with difficult problems at the intersection of technology and society and the challenge of keeping up with brilliant colleagues. Exponent has both of those in spades, and I'm excited to join the team."

— Tom Watt, Principal, Computer, Data & Security Sciences

About Exponent's Computer, Data & Security Sciences Practice

Exponent's Computer, Data & Security Sciences practice combines multidisciplinary technical expertise with domain insights to help clients navigate fast-moving advances in computing, data, and security. The practice supports organizations in areas including software and computer systems, cybersecurity, data science, intellectual property, product development, artificial intelligence, and government-sector consulting.

Insights

Engineer wearing a hard hat and safety vest, inspecting red industrial fire sprinkler pipes and checking blueprints, ensuring system integrity and safety in a commercial building

Expert Perspective

Can AI Make Fire Protection Smarter — and Safer?

Industry Analysis

A Multidisciplinary Approach to Technical Due Diligence

Announcement

David Walters Joins Exponent as New Principal

Alerts

U.S. Expands Restrictions on Foreign Technology

Thought leadership

Addressing Cyber Risk in Water & Wastewater Operations

Subscribe to Exponent's Insights

Click here

Exponent Declares Regular Quarterly Dividend for Q4 2026 Bull 0 Bear 0 Capital return

10/29/2026

Download(opens in new window)

MENLO PARK, Calif., Oct. 29, 2026 (GLOBE NEWSWIRE) -- Exponent, Inc. (Nasdaq: EXPO) today announced that its Board of Directors has declared a quarterly cash dividend of $0.31 per share of common stock to be paid on December 18, 2026 to all common stockholders of record as of December 4, 2026.

Exponent has paid, and expects to continue to pay, quarterly dividends each year in March, June, September, and December. Future declarations of quarterly dividends and the establishment of future record and payment dates are subject to the final determination of Exponent’s Board of Directors.

“Our quarterly cash dividend reflects the consistency of Exponent’s cash generation and our continued commitment to returning capital to shareholders,” commented Dr. Catherine Corrigan, Chief Executive Officer. “Our disciplined approach to capital allocation, supported by a strong balance sheet, allows us to return capital to shareholders while continuing to invest in the people and capabilities that drive long-term growth.”

About Exponent

Prompts

Exponent, Inc. (ticker EXPO), listed in United States.

ETFs Holding Exponent, Inc.

ETF Weight in ETF Shares Market value As of
SDVD 0.81% 86,208 $ 7.431M Nov 11, 2026
FSML 0.73% 15,569 $ 914.834K Jun 30, 2026
WCEO 0.62% 922 $ 61.636K Jul 31, 2026
LITL 0.59% 385 $ 33.761K Nov 17, 2026
PAPI 0.42% 28,642 $ 1.683M Jun 30, 2026
SEIS 0.24% 23,975 $ 1.409M Jun 30, 2026
AVSC 0.22% 78,441 $ 6.917M Nov 16, 2026
PSC 0.17% 68,466 $ 4.023M Jun 30, 2026
JMEE 0.16% 51,099 $ 4.481M Nov 17, 2026
RESM 0.13% 80 $ 4,700.80 Jun 30, 2026
DFAS 0.09% 365,257 $ 31.492M Nov 12, 2026
SMDX 0.08% 1,169 $ 103.082K Nov 17, 2026
SFGV 0.04% 5,848 $ 510K Nov 18, 2026
DXUV 0.02% 16,203 $ 1.397M Nov 12, 2026
AVSU 0.02% 830 $ 73.189K Nov 16, 2026
AVUQ 0.02% 960 $ 84.653K Nov 16, 2026
DFSU 0.02% 4,825 $ 416.012K Nov 12, 2026
DFAC 0.01% 145,469 $ 12.542M Nov 12, 2026
MSSM 0.01% 1,290 $ 91.603K Aug 31, 2026
DCOR 0.01% 53,755 $ 4.635M Nov 12, 2026
AVUS 0.01% 21,518 $ 1.897M Nov 16, 2026
DFUS 0.01% 15,680 $ 1.352M Nov 12, 2026
DFAU 0.00% 7,160 $ 617.335K Nov 12, 2026
EBI 0.00% 36 $ 2,556.36 Aug 31, 2026
DFUV 0.00% 37 $ 3,190.14 Nov 12, 2026